N@N

Market Maker Surveillance Report. GERN, PPHM, OXM, UEPS, CUR, MFRM, Losing Stocks With Lowest Price Friction For Tuesday, Dece

December 4, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4162 companies with "abnormal" market making, 2503 companies with positive Friction Factors and 2920 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Geron Corp (NASDAQ:GERN), Peregrine Pharmaceuticals Inc (NASDAQ:PPHM), Oxford Industries Inc (NYSE:OXM), Net 1 UEPS Technologies Inc (NASDAQ:UEPS), Diagnocure Inc (AMEX:CUR), Mattress Firm Holding Corp (NASDAQ:MFRM). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  GERN    $-0.340   -22.97%   2,931,437    48.37%    3,088,847    50.97%    -157,410     -4,630  
  PPHM    $-0.170   -11.56%   3,647,016    40.66%    5,312,019    59.23%    -1,665,003   -97,941 
  OXM     $-6.420   -11.58%   52,596       22.16%    56,164       23.67%    -3,568       -6      
  UEPS    $-4.620   -58.93%   5,568,398    46.86%    6,292,854    52.96%    -724,456     -1,568  
  CUR     $-0.310   -20.81%   1,989,783    27.76%    2,761,504    38.53%    -771,721     -24,894 
  MFRM    $-4.880   -16.90%   482,926      48.83%    500,889      50.65%    -17,963      -37     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows GERN with a dollar loss Tuesday of $-0.34000 and a Friction Factor of -4,630 shares. That means that it only took 4,630 more shares of selling than buying to move GERN lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

Geron Corp (NASDAQ:GERN) - Geron Corporation, a biopharmaceutical company, develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, and diabetes. It develops a range of anti-cancer therapies based on telomerase inhibitors and telomerase therapeutic vaccines; and diagnostics based on telomerase detection, as well as intends to develop products using telomerase as a marker for cancer diagnosis, prognosis, patient monitoring, and screening. The company develops Imetelstat (GRN163L), which is in Phase I clinical trial for the treatment of chronic lymphoproliferative diseases, solid tumors, multiple myeloma, and non-small cell lung cancer. GRN163L is also in Phase I/II clinical trial to treat breast cancer. The company also develops GRNVAC1 that is in Phase II clinical trial for the treatment of acute myelogenous leukemia. It also develops GRNOPC1, which is in Phase I Trial for treatment of spinal cord injury; and GRNCM1 that is in preclinical stage to treat heart disease and screening. The company has licensing agreement with Merck & Co. to develop telomerase cancer vaccine, which is in Phase I clinical trial for the treatment of prostate and solid tumors; Sienna Cancer Diagnostics to develop a preclinical stage product for the treatment of bladder cancer; and has a collaboration with the University Campus Suffolk to develop human embryonic stem cell-derived chondrocytes for the treatment of cartilage damage and joint disease. Geron Corporation was founded in 1990 and is based in Menlo Park, California..

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM) - Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development and manufacture of monoclonal antibodies for the treatment of cancer and viral infections. The company develops clinical programs with its novel compounds bavituximab and Cotara, which are the clinical candidates under its anti-phosphatidylserine therapeutics and tumor necrosis therapy platforms. Its pipeline products comprise Bavituximab Plus Docetaxel, and Bavituximab plus carboplatin and paclitaxel, which are Phase II clinical trial products for treating advanced breast cancer patients; and Bavituximab plus carboplatin and paclitaxel, a Phase II clinical trial product for the treatment of non-small cell lung cancer, as well as Bavituximab, which is in Phase I monotherapy repeat dose safety study for treating solid tumor cancers, and in Phase Ib repeat dose safety study for the treatment of chronic hepatitis C virus infection co-infected with HIV. In addition, its pipeline products include Cotara, a product in Phase II, as well as a dosimetry and dose confirmation study for the treatment of glioblastoma multiforme, an aggressive form of brain cancer. Further, Peregrine, through its wholly owned subsidiary, Avid Bioservices, Inc., provides contract manufacturing services for biotechnology and biopharmaceutical companies, from pre-clinical drug supplies up through commercial-scale drug manufacture. Further, it provides services in support of Peregrine's product pipeline, including manufacture and scale-up of pre-clinical and clinical drug supplies. The company was founded in 1981 and is based in Tustin, California..

Oxford Industries Inc (NYSE:OXM) - Oxford Industries, Inc. engages in the design, production, sale, and distribution of branded and private label apparel for men and women primarily in the United States and the United Kingdom. The companys products include branded and private label dress shirts, suited separates, sport shirts, casual slacks, outerwear, sweaters, jeans, swimwear, westernwear, and golf apparel products, as well as tailored clothing products and accessories. Its brands include Tommy Bahama, Ben Sherman, Ely, Nickelson, Cattleman, Oxford Golf, Cumberland Outfitters, Arnold Brant, and Billy London. The company also holds licenses to produce and sell various categories of apparel products under the Kenneth Cole, Dockers, Geoffrey Beene, and United States Polo Association brand names. Its third party license arrangements for its Tommy Bahama products include mens and womens watches, eyewear, belts and socks, and fragrances; shampoo, soap, and bath amenities; ceiling fans; rugs; wallcoverings; luggage; indoor and outdoor furniture; bedding and bath linens; and table top accessories. The companys third party license arrangements for Ben Sherman products comprise footwear, kids apparel, backpacks, travel bags, suits, dress shirts, watches, jewelry, underwear, socks, sleepwear, eyewear, gift products, fragrances, toiletries, accessories, wallets, small leather goods, neckwear, pocket squares, hats, caps, scarves, gloves, and belts. It primarily distributes its products through wholesale distribution channels, including national chains, department stores, mass merchants, specialty stores, specialty catalog retailers, and Internet retailers, as well as through its owned and licensed retail stores and e-commerce Websites. In addition, the company operates restaurants. Oxford Industries was founded in 1942 and is based in Atlanta, Georgia..

Net 1 UEPS Technologies Inc (NASDAQ:UEPS) - Net 1 UEPS Technologies, Inc. provides universal electronic payment system (UEPS) as an alternative payment system for the unbanked and under-banked populations in South Africa. The companys UEPS system uses secure smart cards that operate in real time but offline, which means users of the system can enter into transactions at any time with other card holders in even the remote areas; and can be used for banking, health care management, international money transfers, voting, and identification. The company operates in four segments: Transaction-Based Activities; Smart Card Accounts; Financial Services; and Hardware, Software, and Related Technology Sales. The Transaction-Based Activities segment provides state pension and welfare benefit distribution services to provincial governments and transaction processing for retailers, utilities, and banks. This segment also offers payment of social welfare grants, debit orders, and wages; point of sale spending; distribution of medicine; money transfers; prepayment of utility bills and mobile phone airtime; and transaction fees. The Smart Card Accounts segment provides smart card accounts, which primarily consist of social welfare grant beneficiaries to its card holders. The Financial Services segment facilitates short-term loans and life insurance products to the card holders through the smart card delivery channel. The Hardware, Software, and Related Technology Sales segment offers hardware and software required to implement its UEPS system, as well as develops and provides prism secure transaction technology, solutions, and services. Net 1 UEPS Technologies, Inc. also leases terminals to merchants and provides an automated payment collection service to third parties. It primarily serves financial, retail, telecommunication, utilities, and petroleum sectors. The company was founded in 1989 and is headquartered in Johannesburg, South Africa..

Diagnocure Inc (AMEX:CUR) - Neuralstem, Inc., a biopharmaceuticals company, focuses on the development and commercialization of treatments for central nervous system diseases based on transplanting human neural stem cells and small molecule drugs. It uses its proprietary human neural stem cell technology as a tool for use in the small-molecule drug discovery, as well as to create cell therapy biotherapeutics for the treatment of central nervous system diseases, various neurodegenerative conditions, and for the regenerative repair of acute diseases. The company was founded in 1996 and is headquartered in Rockville, Maryland..

Mattress Firm Holding Corp (NASDAQ:MFRM) - .

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net